4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-22-004178
CEO and CFO bought 5,500 shares at $19.80 ($108,900)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2022-02-11 | Purchase | +5,500 | $19.80 | $108,900 | 1,204,929 | D |
| Open-market purchases · 5,500 sh · avg $19.80 · $108,900 | |||||||
Loading xslF345X03/ownership.xml…